Gilead Sciences Inc (GILD) Common Stock USD0.001
Sell:$125.85Buy:$125.90
$1.67
(1.31%)
NASDAQ:
0.65%
0.65%Market closed |
Prices delayed by at least 15 minutes
- This stock can be held in a
Create an alert
Stocks and Shares ISASell:$125.85
Buy:$125.90
Change:$1.67
(1.31%)
$1.67
(1.31%)Market closed |
Prices delayed by at least 15 minutes
Sell:$125.85
Buy:$125.90
Change:$1.67
(1.31%)
$1.67
(1.31%)Market closed |
Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 17 November 2025 | Andrew D (Andy) DickinsonCFO | Sell Regular sell transaction (market) | 2,500 | $125.23 | $313,075.00 | 154,555 |
| 17 November 2025 | Johanna MercierChief Level Officer | Sell Regular sell transaction (market) | 25,524 | $125.83 | $3,211,559.85 | 109,669 |
| 17 November 2025 | Johanna MercierChief Level Officer | Sell Option/Award related | 2,476 | $126.26 | $312,613.57 | 107,193 |
| 12 November 2025 | Deborah H. (Deb) TelmanGeneral Counsel | Sell Option/Award related | 17,181 | $124.00 | $2,130,444.00 | 43,676 |
| 12 November 2025 | Deborah H. (Deb) TelmanGeneral Counsel | Sell Option/Award related | 35,965 | $122.30 | $4,398,591.43 | 43,676 |
| 12 November 2025 | Deborah H. (Deb) TelmanGeneral Counsel | Sell Option/Award related | 500 | $122.90 | $61,452.00 | 43,676 |
| 28 October 2025 | Daniel Patrick O'DayChairman/CEO | Sell Regular sell transaction (market) | 7,978 | $119.54 | $953,666.98 | 583,225 |
| 28 October 2025 | Daniel Patrick O'DayChairman/CEO | Sell Regular sell transaction (market) | 2,022 | $118.82 | $240,258.69 | 581,203 |
| 25 October 2025 | Deborah H. (Deb) TelmanGeneral Counsel | Sell Tax related | 241 | $120.94 | $29,146.54 | 43,676 |
| 15 October 2025 | Andrew D (Andy) DickinsonCFO | Sell Regular sell transaction (market) | 2,500 | $118.08 | $295,200.00 | 157,055 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 12 February 2025 | Andrew D (Andy) DickinsonCFO | Sell Option/Award related | 137,676 | $102.22 | $14,073,240.72 | 171,223 |
| 31 January 2025 | Andrew D (Andy) DickinsonCFO | Sell Option/Award related | 142,180 | $97.22 | $13,822,739.60 | 129,873 |
| 4 February 2025 | Daniel Patrick O'DayChairman/CEO | Sell Tax related | 108,156 | $97.99 | $10,598,206.44 | 617,876 |
| 4 February 2025 | Johanna MercierChief Level Officer | Sell Tax related | 45,666 | $97.99 | $4,474,811.34 | 119,979 |
| 12 November 2025 | Deborah H. (Deb) TelmanGeneral Counsel | Sell Option/Award related | 35,965 | $122.30 | $4,398,591.43 | 43,676 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.